Vivani Medical (NASDAQ:VANI – Get Free Report) and Precision Optics (NASDAQ:POCI – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, institutional ownership, analyst recommendations and profitability.
Profitability
This table compares Vivani Medical and Precision Optics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Vivani Medical | N/A | -102.42% | -49.21% |
| Precision Optics | -20.01% | -35.51% | -21.67% |
Institutional & Insider Ownership
6.8% of Vivani Medical shares are held by institutional investors. Comparatively, 13.7% of Precision Optics shares are held by institutional investors. 44.3% of Vivani Medical shares are held by company insiders. Comparatively, 16.3% of Precision Optics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Risk & Volatility
Valuation & Earnings
This table compares Vivani Medical and Precision Optics”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Vivani Medical | N/A | N/A | -$25.65 million | ($0.45) | -2.73 |
| Precision Optics | $18.98 million | 1.71 | -$2.95 million | ($0.62) | -8.23 |
Precision Optics has higher revenue and earnings than Vivani Medical. Precision Optics is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of recent ratings and target prices for Vivani Medical and Precision Optics, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Vivani Medical | 0 | 0 | 1 | 0 | 3.00 |
| Precision Optics | 0 | 0 | 0 | 0 | 0.00 |
Vivani Medical currently has a consensus price target of $3.00, suggesting a potential upside of 143.90%. Given Vivani Medical’s stronger consensus rating and higher probable upside, equities analysts clearly believe Vivani Medical is more favorable than Precision Optics.
Summary
Vivani Medical beats Precision Optics on 8 of the 13 factors compared between the two stocks.
About Vivani Medical
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
About Precision Optics
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
